Wedbush Initiates Coverage On Trex Bio with Outperform Rating, Announces Price Target of $30

Benzinga · 1d ago
Wedbush analyst Martin Fan initiates coverage on Trex Bio (NASDAQ:TRXB) with a Outperform rating and announces Price Target of $30.